Idenix to Webcast Conference Call Discussing Second Quarter 2005 Financial Results

Idenix to Webcast Conference Call Discussing Second Quarter 2005
Financial Results 


CAMBRIDGE, Mass., July 18  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals,
Inc., (NASDAQ:IDIX) today announced that it will report its financial results
for the second quarter 2005 on Thursday, July 28, 2005, after the U.S.
financial markets close.

In conjunction with the issuance of the press release, management will host a
conference call at 4:30 p.m. EDT on Thursday, July 28, 2005, to discuss the
company's financial results for the second quarter of 2005, provide an update
on its clinical programs and review 2005 financial guidance and milestones.

A live audio webcast of the call will be available under "Events" in the Idenix
Investor Center at http://www.idenix.com/.  An archived webcast will be
available on the Idenix website for two weeks after the call.  A replay of the
call will also be available from 8:00 p.m. EDT on July 28, 2005, until 8:00
p.m. EDT on August 12, 2005.  To access the replay, please dial 800-642-1687 or
706-645-9291 (international), and provide the access code 7851229.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of infections
caused by hepatitis B virus, hepatitis C virus and human immunodeficiency
virus. Idenix's headquarters are located in Cambridge, Massachusetts and it has
drug discovery operations in Montpellier, France and Cagliari, Italy.  For more
information on Idenix, please visit http://www.idenix.com/.

  Contact:
   Idenix Pharmaceuticals, Inc.
   Media: Teri Dahlman [phone]
   Investors: Amy Sullivan [phone]


DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT: Media: Teri Dahlman, [phone], or Investors: Amy

Sullivan, [phone] both of Idenix Pharmaceuticals, Inc.



Web site:  http://www.idenix.com/

Copyright